A considerable proportion of first heart failure diagnoses occur in the acute care setting, but many patients have potential symptoms in the six months prior to diagnosis.
For Medicare beneficiaries with implantable cardioverter defibrillators (ICDs), physical activity (PA) is associated with a reduction in all-cause mortality.
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
The prevalence of myocarditis in athletes following symptomatic or asymptomatic COVID-19 infection and compare screening strategies for safe return to play.
From 2008 to 2018, there was a sharp increase in methamphetamine-associated cardiomyopathy/heart failure (MethHF) hospitalizations and related costs in California.
